News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
124 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17865)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (18)
2 (269)
3 (285)
4 (247)
5 (261)
6 (107)
7 (40)
8 (30)
9 (292)
10 (264)
11 (234)
12 (208)
13 (114)
14 (2)
15 (9)
16 (225)
17 (227)
18 (243)
19 (266)
20 (124)
21 (3)
22 (2)
23 (119)
24 (14)
25 (1)
26 (39)
27 (24)
28 (1)
29 (2)
30 (88)
31 (41)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Eureka 93 Inc. Restructures and Executes a Partial Payment Transaction for Discharge of Material Partial Secured Debt Obligation
Eureka 93 Inc. (CSE: ERKA, “Eureka93”) announced today that the current Board of Directors, after having reviewed strategic alternatives, approved a partial restructuring of its debt by executing a partial payment transaction for discharge of a material secured debt obligation.
December 20, 2019
·
3 min read
Deals
LABORIE Medical Technologies to Acquire Clinical Innovations, Leading Global Medical Device Company Focused on Labor & Delivery and Neonatal Intensive Care Specialties
LABORIE Medical Technologies, a leading global developer and manufacturer of medical diagnostics and devices in the pelvic health and gastroenterology market, today announces the execution of a definitive agreement to acquire Clinical Innovations for an enterprise value of $525 million.
December 20, 2019
·
4 min read
Deals
Monopar Therapeutics Inc. Announces Full Exercise of Over-Allotment by Underwriters
Monopar Therapeutics Inc. today announced that the underwriters of its previously announced initial public offering of common stock have exercised in full their option to purchase an additional 166,666 shares of common stock
December 20, 2019
·
1 min read
Policy
Cook Medical Applauds Congressional Action to Repeal the Medical Device Excise Tax
Cook Medical applauds the successful efforts of legislators from the U.S. Senate and House of Representatives to repeal the medical device excise tax..
December 20, 2019
·
1 min read
Previous
13 of 13